ArticleNeurology(R) neuroimmunology & neuroinflammation2021

Mild progressive multifocal leukoencephalopathy after switching from natalizumab to ocrelizumab.

Alyssa A Toorop et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.